MedPath

Investigating the effect of rose vaginal gel on postmenopausal women’s menopausal symptoms

Not Applicable
Recruiting
Conditions
Menopausal symptoms score.
Menopausal and female climacteric states
N95.1
Registration Number
IRCT20130812014333N219
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
44
Inclusion Criteria

At least one year has passed since the last menstrual period or having a hormone test with an FSH level greater than 40 international units
Obtaining a score of 5 or more from the MRS questionnaire
Age between 45 and 65 years
Being married
Absence or history of uterine and breast cancer

Exclusion Criteria

Having uterine bleeding or spotting with an unknown cause
Vaginal infection requires treatment
Abnormalities of the genital system
Under sex hormone therapy within 8 weeks before the study
Use of vaginal drugs or any lubricants at least 15 days before the study
Smoking (alcohol, cigarettes, hookah)
Body mass index more than 30 kg/m2
Cholestatic liver disorders, severe kidney failure, acute thromboembolism and high blood pressure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hot flushes. Timepoint: before the start of the study, 2, 6 and 12 weeks after the intervention. Method of measurement: Ask the patient.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath